Researchers Build a Better Antibody to Supercharge Cancer-Fighting T Cells
Researchers have engineered a new type of antibody with four prongs instead of two, designed to better activate the immune system’s T cells against cancer. By clustering receptors called CD27, the antibodies mimic a stronger natural signal, showing promise in lab tests with mice and human cells.